Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Immuno-Biological Laboratories Co Ltd (4570)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
460.0 -2.0    -0.43%
02/05 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 36,500
  • Bid/Ask: 460.0 / 464.0
  • Day's Range: 456.0 - 465.0
Type:  Equity
Market:  Japan
ISIN:  JP3921300004 
Immuno-Biological Laboratories 460.0 -2.0 -0.43%

4570 Balance Sheet

 
Assess the latest Immuno-Biological Laboratories Co Ltd balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 4570 Annual Report data, financial summaries and charts are available for Immuno-Biological Laboratories Co Ltd investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 1155 1159 1155 1165
Cash and Short Term Investments 629 621 605 614
Cash - - - -
Cash & Equivalents 629 621 605 614
Short Term Investments - - - -
Total Receivables, Net 178 198 215 217
Accounts Receivables - Trade, Net 178 198 215 217
Total Inventory 331 324 318 318
Prepaid Expenses - - - -
Other Current Assets, Total 17 16 17 16
Total Assets 1434 1434 1427 1434
Property/Plant/Equipment, Total - Net 118 118 118 119
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments 160 156 153 149
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 1 1 1 1
Other Assets, Total 170 142 120 117
Total Current Liabilities 235 223 232 252
Accounts Payable 5 3 4 5
Payable/Accrued - - - -
Accrued Expenses 13 27 13 25
Notes Payable/Short Term Debt 135 135 130 130
Current Port. of LT Debt/Capital Leases 11 5 6 5
Other Current liabilities, Total 71 53 79 87
Total Liabilities 335 329 338 356
Total Long Term Debt 90 97 97 99
Long Term Debt 90 97 97 99
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total -125 -126 -218.47 -324.1
Total Equity 1099 1105 1089 1078
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 50 50 3029 3029
Additional Paid-In Capital 1040 1040 2061 2061
Retained Earnings (Accumulated Deficit) 10 17 -3998 -4009
Treasury Stock - Common -1 -1 -1 -1
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - -1 -2 -2
Total Liabilities & Shareholders' Equity 1434 1434 1427 1434
Total Common Shares Outstanding 9.31 9.31 9.31 9.31
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4570 Price Commentary

Write your thoughts about Immuno-Biological Laboratories Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email